Stock Market logoStock Market Station

All the stock market news, every minute updated!

16 June 2021
10:37 hour

Hot Stocks: Gamestop skepticism, IPO winners, RH demand surge, the risks/rewards of drug development

Seeking Alpha

10/06/2021 - 23:29


READ THE FULL ARTICLE ON SEEKING ALPHA

Related headlines:

  1. Chinese firm's COVID-19 drug claims draw skepticism (14/05/2021 - Investing.com)

    [visit article]
  2. Hot Stocks: Bitcoin stocks still in focus, DKNG falling on research call, more drug development news (15/06/2021 - Seeking Alpha)

    [visit article]
  3. Capitol Report: Robinhood back in DC spotlight amid surge in GameStop shares (16/03/2021 - Market Watch)
    The House Financial Services Committee will continue its investigation into the short squeeze of shares of GameStop Inc. and other meme stocks on Wednesday.
    [visit article]
  4. Capitol Report: Robinhood back in DC spotlight amid surge in GameStop shares (16/03/2021 - Market Watch)
    The House Financial Services Committee will continue its investigation into the short squeeze of shares of GameStop Inc. and other meme stocks on Wednesday.
    [visit article]
  5. GameStop, AMC surge as 'meme stocks' rally returns (26/05/2021 - Seeking Alpha)

    [visit article]
  6. DRDO new drug: What is 2-DG medicine and how it works explained (18/05/2021 - Financial Express)
    The Defence Research and Development Organisation (DRDO) has produced a new drug that can be used to treat the novel Coronavirus.
    [visit article]
  7. Hot Stocks: Tesla makes Plaid sexy, big drug development moves, PLAY gets play (11/06/2021 - Seeking Alpha)

    [visit article]
  8. Battling Coronavirus: Local anti-Covid drug 2-DG to hit markets in June (18/05/2021 - Financial Express)
    The drug has been developed by the Institute of Nuclear Medicine and Allied Sciences (INMAS), a laboratory under the Defence Research and Development Organisation (DRDO), in collaboration with pharma major Dr Reddy’s Laboratories (DRL).
    [visit article]
  9. Trade recovery: Exports surge 69% in May on improved demand (16/06/2021 - Financial Express)
    Having witnessed an impressive rate of expansion last fiscal in the wake of the Covid-19 outbreak, drug and pharmaceutical exports dropped by 5.4% in May to $1.9 billion, thanks to decreasing Covid cases in the US and the EU.
    [visit article]
  10. : People of color face multiple barriers to vaccine access — including ‘skepticism of a system that has treated them poorly’ (26/04/2021 - Market Watch)
    'The demand is there,' said Nida Al-Ramahi, a Penn Medicine administrative fellow.
    [visit article]
  11. Anti-COVID drug developed by DRDO for emergency use gets approved (08/05/2021 - Financial Express)
    INMAS, a Defence Research and Development Organisation (DRDO), has along with Dr Reddy’s Laboratories (DRL), Hyderabad have developed this drug, which already undergone clinical trials, in which this molecule helps in faster recovery of hospitalised patients.
    [visit article]
  12. Thoughts on Aprea Therapeutics (APRE) (08/04/2021 - Reddit Stocks)
    Stock is up 15% today. They've been trading $20-30 last year and currently averaging $5. Price target is set to $8-10, but I believe there's more room to grow. Hold / Strong buy to me. What do you think? Company Summary Aprea Therapeutics Inc. is a biopharmaceutical company. It is focused on developing and commercializing novel cancer therapeutics which reactivate the mutant tumor suppressor protein, p53. The Company's lead drug candidate, APR-246, a first-in-class small molecule p53 reactivator, is in clinical development for myelodysplastic syndromes, acute myeloid leukemia as well as additional hematologic and solid tumor malignancies. Todays News: Aprea Therapeutics shares jump (APRE +15.3%) after the FDA granted Orphan Drug designation to eprenetapopt for treatment of acute myeloid leukemia (AML). Orphan Drug status is granted by the FDA Office of Orphan Products Development to advance the evaluation and development of safe and effective therapies for the treatment of rare diseases or conditions affecting fewer than 200K people in the U.S. The designation can provide development and commercial incentives for designated compounds and medicines, including eligibility for a seven-year period of market exclusivity in the U.S. upon approval.   submitted by   /u/CrossOffTheDaysGone [link]   [comments]
    [visit article]
  13. DRDO’s Covid drug 2-DG expected to be in the market in June, says DRL (18/05/2021 - Financial Express)
    As has been reported earlier this anti-COVID-19 therapeutic application of the drug 2-deoxy-D-glucose (2-DG) has been jointly developed by Institute of Nuclear Medicine and Allied Sciences (INMAS), Defence Research and Development Organisation (DRDO), and Dr Reddy’s Laboratories (DRL), Hyderabad.
    [visit article]
  14. : Retail traders keep meme stocks short squeezed for third straight day (26/05/2021 - Market Watch)
    GameStop and AMC surge again as retail traders see proof that short sellers are still messing with their favorite stocks.
    [visit article]
  15. : Retail traders keep meme stocks short squeezed for third straight day (26/05/2021 - Market Watch)
    GameStop and AMC surge again as retail traders see proof that short sellers are still messing with their favorite stocks.
    [visit article]
  16. Evotec: second short squeeze taking off now ???? (16/02/2021 - Reddit Stock Market)
    Evotec is presently Germany's most shorted stock. This is unjustified, as the drug development company has great prospects. They develop drugs for a range of diseases, from Alzheimer's and Huntington's disease, diabetes and cancer, to infectious diseases. The company has just entered into an "integrated multi-target drug discovery agreement with biotech venture creation firm Related Sciences to generate multiple drug development candidates, biomarkers, and IND filings over a multi-year period.": http://mobile.dgap.de/dgap/News/corporate/evotec-and-related-sciences-enter-integrated-drug-discovery-and-development-partnership/?newsID=1421971 Last week, the stock rose from 30 to 38 EUR, while the proportion of shorted shares declined from around 12.5% to 6.8%. You can nicely see here how Melvin Capital, the biggest short seller, started to pull out: https://shortsell.nl/short/EvotecSE/90/archived The stock price then dropped a few euros and has since climbed consistently and faster over time. Another short squeeze seems to be taking off now (!). Take a look at the chart! I'm not a financial advisor, but I think this stock will go up in the coming days ????.   submitted by   /u/Fantastic-Notice-544 [link]   [comments]
    [visit article]
  17. NewsWatch: We put AMC, GameStop and other meme stocks’ numbers to the test — here’s which ones came out on top (04/06/2021 - Market Watch)
    AMC, GameStop and Nokia are lumped together, but not all meme stocks are alike — whether you are a day-trader or a long-term investor.
    [visit article]
  18. : GameStop hearing challenges assumptions about rookie investors — ‘Retail investors making up this new surge are different’ (18/02/2021 - Market Watch)
    Robinhood CEO Vlad Tenev discussed average account sizes and user demographics during a congressional hearing on GameStop's rise and fall.
    [visit article]
  19. NewsWatch: GameStop hearing challenges assumptions about rookie investors — ‘Retail investors making up this new surge are different’ (18/02/2021 - Market Watch)
    Robinhood CEO Vlad Tenev discussed average account sizes and user demographics during a congressional hearing on GameStop's rise and fall.
    [visit article]
  20. : AMC soars and this time GameStop follows as meme stocks get squeezed hard (13/05/2021 - Market Watch)
    Meme stocks are playing role reversal with AMC Entertainment’s Thursday short squeeze pulling up shares in retail stock GameStop too.
    [visit article]
  21. Cybin inks drug development agreement with Catalent (22/03/2021 - Seeking Alpha)

    [visit article]
  22. Market Extra: GameStop’s 53% surge fueled by a buy/sell ratio of 3-to-1, as ‘meme’ stock crowd emboldened (26/03/2021 - Market Watch)
    After taking a pummeling over the first three days of the week, shares of GameStop Corp. soar Thursday, aided by retail traders who remain emotionally committed to the videogame retailer even after shares got hammered 24 hours earlier.
    [visit article]
  23. Oncology Pharma lines up CRO deal to assist drug development (10/03/2021 - Seeking Alpha)

    [visit article]
  24. Pharmas engaged in Alzheimer's, the 'holy grail' of drug development (13/02/2021 - Seeking Alpha)

    [visit article]
  25. Beam Therapeutics names drug development expert as medical chief (15/03/2021 - Seeking Alpha)

    [visit article]
  26. Daiichi Sankyo ends development of drug under investigation as COVID-19 treatment (15/06/2021 - Seeking Alpha)

    [visit article]
  27. Emmaus strikes deal with Kainos Medicine in anti-cancer drug development (02/03/2021 - Seeking Alpha)

    [visit article]
  28. Entera Bio continues surge following osteoporosis drug results; up 52% premarket (12/03/2021 - Seeking Alpha)

    [visit article]
  29. Can-Fite shares surge 75% on out-licensing psoriasis, liver disease drug rights (16/03/2021 - Seeking Alpha)

    [visit article]
  30. : GameStop Round 2? How an options-buying frenzy is providing another jolt to ‘meme’ stocks (25/02/2021 - Market Watch)
    Investors are taking another run at GameStop Corp. and other 'meme' stocks by aggressively buying out-of-the-money call options. Here's how it works.
    [visit article]
  31. GameStop rallies after CEO development as sell-side continues to doubt valuation (19/04/2021 - Seeking Alpha)

    [visit article]
  32. GameStop tumbles nearly 20% as retail-driven surge dies down (09/02/2021 - Investing.com)

    [visit article]
  33. : Meme stocks stumble after GameStop discloses SEC probe into the frenzy (10/06/2021 - Market Watch)
    The big meme stocks all took a hit in after-hours trading Wednesday as GameStop discloses SEC probe and willingness to fully cooperate with the regulator's inquiry.
    [visit article]
  34. Riskiest stocks you are in? (24/04/2021 - Reddit Stocks)
    I saw somebody post about if people on this sub take risks, so this is a chance for everyone to post their riskiest stocks. Most of my risky stocks/speculative stocks are Biotech - TRIL, PAVM, ONCT, etc. Would love to know what everyone is taking risks on and why. Cheers!   submitted by   /u/checksout101520 [link]   [comments]
    [visit article]
  35. The Apes Are Being Treated As ATM According to Gamestop latest 10k (SEC Link INCLUDED) (23/03/2021 - Reddit Stock Market)
    Looking at this 10k filing just now. GameStop came up a genius term call ATM at the market offering to sell stocks. NOW they are out of the quiet period after earning. I don't know if there will be a short squeeze if Gamestop and its employee are selling their share at their once-a-lifetime opportunity. The executive team was selling at 20 and 30. I'm sure they will sell again for 200. The recent executive departures are unlikely due to transformation. It's like being branded as it is. The truth I'm guessing is that their people just want to sell everything and retired early. https://news.gamestop.com/node/18661/html ​ GME ATM   submitted by   /u/tianababy [link]   [comments]
    [visit article]
  36. : GameStop and AMC stocks spike anew, as Reddit struggles to stay online (24/02/2021 - Market Watch)
    Shares in GameStop Corp. and AMC Entertainment Holdings Inc. suddenly resumed spiking late in Wednesday's trading session, as Reddit --- the online message board where investors gathered to discuss their interest in those stocks previously --- suffered from outages.
    [visit article]
  37. : GameStop and AMC stocks spike anew, as Reddit struggles to stay online (24/02/2021 - Market Watch)
    Shares in GameStop Corp. and AMC Entertainment Holdings Inc. suddenly resumed spiking late in Wednesday's trading session, as Reddit --- the online message board where investors gathered to discuss their interest in those stocks previously --- suffered from outages.
    [visit article]
  38. Covid-19 Surge; Turkey Turmoil, GameStop Earnings - What's up in Markets (22/03/2021 - Investing.com)

    [visit article]
  39. NewsWatch: As AMC Entertainment stock surges 20%, SEC says it’s watching memes for ‘disruptions of the market, manipulative trading, or other misconduct’ (07/06/2021 - Market Watch)
    The U.S. Securities and Exchange Commission warns that it is closely monitoring moves in the market, amid the surge in values of meme stocks AMC Entertainment and GameStop Corp.
    [visit article]
  40. This penny stock is up 500% since January 2020. Should I buy now? (16/03/2021 - The Motley Fool UK)
    The share price of E-Therapeutics (LSE:ETX) was on fire throughout all of 2020 and has continued to rise since. The penny stock was priced at 3.75p back in January last year. But today is much closer to 23p. What caused this 510% surge? And should I be adding the business to my portfolio? Let’s take a look. A tech solution to drug development E-Therapeutics is involved in the drug discovery sector of the pharmaceutical industry. Discovering and creating new medicines is a long and expensive process that carries a lot of risks. However, this software company is trying to help change that. It has developed a proprietary platform that incorporates big data and a suite of powerful tools driven by artificial intelligence to accelerate the drug discovery process. And while the technology only recently launched, it is already being used to investigate type-2 diabetes as well as neurodegeneration diseases such as Alzheimer’s and Parkinson’s. Why is the penny stock on the rise? The E-Therapeutics share price started to climb in early 2020, following the release of its results for 2019. It had been a pre-revenue business for many years, and so finally, seeing some form of revenue was exciting. What’s more, overall losses for the year were cut in half, from £5.1m in 2018 to £2.9m in 2019. Combined, this appears to be the primary catalyst for the rising share price. However, I’m far more interested in another announcement made later in the year. In May, E-Therapeutics announced it had expanded its platform’s capabilities to support RNA interference (RNAi). Without going too deeply into gene science, RNAi enables the manipulation of protein behaviour within the body. RNAi-based therapies can treat a wide range of diseases such as cancer and antibiotic-resistant bacterial infections. Today the RNAi drug market is worth approximately $39bn. But current forecasts indicate it will grow by an average of 27.2% annually, reaching a market size of $131bn by 2025. Needless to say, that represents an enormous growth opportunity for this penny stock. Risks to consider As promising as the technology may be, there are some significant risks to consider. The first being the lack of substantial revenue. In 2020, the firm only generated £0.5m, which doesn’t come close to covering the cost of operations. As such, the business is still dependent on outside funding to keep the lights on. What’s more, the company is exposed to some significant cyber-security threats. If a breach were to occur that exposed sensitive client data, E-Therapeutics’ reputation could be severely damaged, leading to a potentially significant reduction in future revenue. The bottom line: a penny stock to buy? The company’s technology is rather impressive in my eyes, especially given the growth opportunities that lie before it. However, even with its recent progress, I believe it’s too soon to invest, especially at its current share price. The market capitalisation of the stock is almost £100m, despite it only generating a tiny amount of revenue. Therefore I’m not adding E-Therapeutics to my portfolio today. But there is another growth stock that looks far cheaper and even more promising… FREE REPORT: Why this £5 stock could be set to surge Are you on the lookout for UK growth stocks? If so, get this FREE no-strings report now. While it’s available: you’ll discover what we think is a top growth stock for the decade ahead. And the performance of this company really is stunning. In 2019, it returned £150million to shareholders through buybacks and dividends. We believe its financial position is about as solid as anything we’ve seen. Since 2016, annual revenues increased 31% In March 2020, one of its senior directors LOADED UP on 25,000 shares – a position worth £90,259 Operating cash flow is up 47%. (Even its operating margins are rising every year!) Quite simply, we believe it’s a fantastic Foolish growth pick. What’s more, it deserves your attention today. So please don’t wait another moment. Get the full details on this £5 stock now – while your report is free. More reading This is what I’m doing about the Argo Blockchain share price right now! ITV shares: 5 things I’d consider before buying These 2 FTSE 100 stocks have thrashed the market but are they too expensive now? FTSE 100: one of the best cheap UK shares to buy before the ISA deadline! This is what I’m doing with the bargain BT share price today Zaven Boyrazian does not own shares in E-Therapeutics. The Motley Fool UK has no position in any of the shares mentioned. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors. The post This penny stock is up 500% since January 2020. Should I buy now? appeared first on The Motley Fool UK.
    [visit article]
  41. GameStop shares surge over 40% after Cohen tapped to lead e-commerce pivot (08/03/2021 - Investing.com)

    [visit article]
  42. Bet on life. Bet on Surface Oncology (02/06/2021 - Reddit Stocks)
    Bet on life. Bet on surface oncology Why don’t we boost stocks that save people’s lives? AMC is great but imagine what we could do if we did the same for cancer companies. One I like is SURF A company with top management that barely dilutes but either raises money through loans or licensing their drugs. In late March the U.S. Food and Drug Administration (FDA) granted an orphan drug designation to SF617, which is intended to treat pancreatic cancer. Surface owns the full rights to SF617, meaning that it will get the full benefits of the designation's package of additional allowances and intellectual property protections if the drug makes it through the clinical trial process. Collaboration with Merck. In the collaboration, Merck's first-line oncology drug, Keytruda, will be investigated in a phase 1 clinical trial in conjunction with Surface's SRF388. Liver cancer and kidney cancer are the intended targets, and investors will get an update on the program's progress in early June, at the American Society of Clinical Oncology's 2021 annual meeting. THIS FRIDAY!!!!! Financially, Surface is in good condition, though it has no recurring revenue as of yet. Its $175 million in cash is more than enough for it to continue with research and development (R&D) work through 2023. License with GSK and Novartis. IND’s coming up. Lots of milestones upcoming in clinical trials. SUB 500M for an immunotherapy company that has PROVEN the drug already works. Get in before this Friday it’s going to blow.   submitted by   /u/HaveADrinkOnMeCosby [link]   [comments]
    [visit article]
  43. Market Extra: As AMC Entertainment stock surges 20%, SEC says it’s watching memes for ‘disruptions of the market, manipulative trading, or other misconduct’ (07/06/2021 - Market Watch)
    The U.S. Securities and Exchange Commission warns that it is closely monitoring moves in the market, amid the surge in values of meme stocks AMC Entertainment and GameStop Corp.
    [visit article]
  44. Gamestop shares surge 104% and “WallStreetBets” is celebrating (25/02/2021 - Reddit Stock Market)
      submitted by   /u/thefoodboylover [link]   [comments]
    [visit article]
  45. Analysis: Micro-cap stock surge shows investor risk taking, GameStop effect (25/02/2021 - Investing.com)

    [visit article]
  46. GameStop – The Second Surge: Anatomy Of A “Gamma Swarm” (Probably the Best Explanation So Far) (11/03/2021 - Reddit Stock Market)
      submitted by   /u/tianababy [link]   [comments]
    [visit article]
  47. US stimulus may fuel another GameStop saga; penny stocks, crypto in focus (19/03/2021 - Financial Express)
    Since the end of February, as the US Congress came closer to passing the stimulus plan, GameStop shares have soared 348%, AMC Entertainment has gained 54%, and Koss Corp has zoomed 114%.
    [visit article]
  48. Goldman Sachs: "biggest jump in oil demand ever" (28/04/2021 - Reddit Stocks)
    https://oilprice.com/Energy/Energy-General/Goldman-Oil-To-Hit-80-On-Largest-Ever-Demand-Jump.html ​ Higher demand for travel and acceleration of vaccinations in Europe are set to result in “the biggest jump in oil demand ever, a 5.2 million barrels per day (bpd) rise over the next six months,” Reuters quoted Goldman Sachs as saying in a note to clients. Goldman Sachs continues to see oil rising to $80 per barrel this summer and says that “The magnitude of the coming change in the volume of demand -- a change which supply cannot match -- must not be understated,” as carried by FXStreet. For those of us who built positions in oil stocks over the last few months things are looking good. A spoiler could be what is going on in India with its Covid surge. If that is indicative of something other than letting their guard down, like the virus variants are truly more contagious, lethal, and vaccine tolerant, then all bets are off. That will be true of all recovery stocks, though. If oil has sustained prices for a few months of $80/b then companies like Suncor will be absolutely minting money. I added more Suncor when it hit $20 last week. I wish I would have bought more.   submitted by   /u/TrioxinTwoFortyFive [link]   [comments]
    [visit article]
  49. Risks regarding AMD? (15/05/2021 - Reddit Stocks)
    I wanted to hear your opinion about AMD. I am considering investing a large portion of my portfolio in AMD and have concerns about two specific risks: If the mining boom slows down because the bubble has burst or something similar, I fear for the demand for graphics cards. I know it's rather partially dedicated mining cards used to mine, but to a large extent GPUs as well. Won't the used market for graphics cards then be flooded with cheap goods and the demand for new graphics cards collapse? Also, many tech companies are starting to design their own chips, for example Apple, Microsoft and Amazon (the latter for their server business). And you can see from Apple's example that they are also very good at this. How do you assess the two risks? Or can you think of other reasons not to buy AMD (or other chip designers)?   submitted by   /u/GordonGekkoVienna [link]   [comments]
    [visit article]

For more information mailto [email protected]. Disclaimer.